These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke. Campbell BCV; Mitchell PJ; Churilov L; Yassi N; Kleinig TJ; Dowling RJ; Yan B; Bush SJ; Dewey HM; Thijs V; Scroop R; Simpson M; Brooks M; Asadi H; Wu TY; Shah DG; Wijeratne T; Ang T; Miteff F; Levi CR; Rodrigues E; Zhao H; Salvaris P; Garcia-Esperon C; Bailey P; Rice H; de Villiers L; Brown H; Redmond K; Leggett D; Fink JN; Collecutt W; Wong AA; Muller C; Coulthard A; Mitchell K; Clouston J; Mahady K; Field D; Ma H; Phan TG; Chong W; Chandra RV; Slater LA; Krause M; Harrington TJ; Faulder KC; Steinfort BS; Bladin CF; Sharma G; Desmond PM; Parsons MW; Donnan GA; Davis SM; N Engl J Med; 2018 Apr; 378(17):1573-1582. PubMed ID: 29694815 [TBL] [Abstract][Full Text] [Related]
7. Arterial occlusion sites on magnetic resonance angiography influence the efficacy of intravenous low-dose (0.6 mg/kg) alteplase therapy for ischaemic stroke. Nakashima T; Toyoda K; Koga M; Matsuoka H; Nagatsuka K; Takada T; Naritomi H; Minematsu K Int J Stroke; 2009 Dec; 4(6):425-31. PubMed ID: 19930051 [TBL] [Abstract][Full Text] [Related]
8. Tenecteplase or Alteplase Better in Patients with Acute Ischemic Stroke Due to Large Vessel Occlusion: A Single Center Observational Study. Teivane A; Jurjāns K; Vētra J; Grigorjeva J; Kupcs K; Masiliūnas R; Miglāne E Medicina (Kaunas); 2022 Aug; 58(9):. PubMed ID: 36143846 [No Abstract] [Full Text] [Related]
9. Safety and Efficacy of Tenecteplase Compared With Alteplase in Patients With Large Vessel Occlusion Stroke: A Prespecified Secondary Analysis of the ACT Randomized Clinical Trial. Bala F; Singh N; Buck B; Ademola A; Coutts SB; Deschaintre Y; Khosravani H; Appireddy R; Moreau F; Phillips S; Gubitz G; Tkach A; Catanese L; Dowlatshahi D; Medvedev G; Mandzia J; Pikula A; Shankar JJ; Williams H; Field TS; Manosalva Alzate A; Siddiqui M; Zafar A; Imoukhoude O; Hunter G; Alhabli I; Benali F; Horn M; Hill MD; Shamy M; Sajobi TT; Swartz RH; Menon BK; Almekhlafi M JAMA Neurol; 2023 Aug; 80(8):824-832. PubMed ID: 37428494 [TBL] [Abstract][Full Text] [Related]
11. Tenecteplase versus alteplase for management of acute ischemic stroke: a pairwise and network meta-analysis of randomized clinical trials. Kheiri B; Osman M; Abdalla A; Haykal T; Ahmed S; Hassan M; Bachuwa G; Al Qasmi M; Bhatt DL J Thromb Thrombolysis; 2018 Nov; 46(4):440-450. PubMed ID: 30117036 [TBL] [Abstract][Full Text] [Related]
12. SYNTHESIS expansion: design of a nonprofit, pragmatic, randomized, controlled trial on the best fast-track endovascular treatment vs. standard intravenous alteplase for acute ischemic stroke. Ciccone A; Valvassori L; Nichelatti M; Int J Stroke; 2011 Jun; 6(3):259-65. PubMed ID: 21557814 [TBL] [Abstract][Full Text] [Related]
13. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study. García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450 [TBL] [Abstract][Full Text] [Related]
14. Effect of Time to Thrombolysis on Clinical Outcomes in Patients With Acute Ischemic Stroke Treated With Tenecteplase Compared to Alteplase: Analysis From the AcT Randomized Controlled Trial. Singh N; Almekhlafi MA; Bala F; Ademola A; Coutts SB; Deschaintre Y; Khosravani H; Buck B; Appireddy R; Moreau F; Gubitz G; Tkach A; Catanese L; Dowlatshahi D; Medvedev G; Mandzia J; Pikula A; Shankar JJ; Ghrooda E; Poppe AY; Williams H; Field TS; Manosalva A; Siddiqui MM; Zafar A; Imoukhoude O; Hunter G; Shamy M; Demchuk AM; Claggett BL; Hill MD; Sajobi TT; Swartz RH; Menon BK Stroke; 2023 Nov; 54(11):2766-2775. PubMed ID: 37800372 [TBL] [Abstract][Full Text] [Related]
15. Early Recanalization Among Patients Undergoing Bridging Therapy With Tenecteplase or Alteplase. Checkouri T; Gerschenfeld G; Seners P; Yger M; Ben Hassen W; Chausson N; Olindo S; Caroff J; Marnat G; Clarençon F; Baron JC; Turc G; Alamowitch S; Stroke; 2023 Oct; 54(10):2491-2499. PubMed ID: 37622385 [TBL] [Abstract][Full Text] [Related]
16. Fingolimod enhances the efficacy of delayed alteplase administration in acute ischemic stroke by promoting anterograde reperfusion and retrograde collateral flow. Tian DC; Shi K; Zhu Z; Yao J; Yang X; Su L; Zhang S; Zhang M; Gonzales RJ; Liu Q; Huang D; Waters MF; Sheth KN; Ducruet AF; Fu Y; Lou M; Shi FD Ann Neurol; 2018 Nov; 84(5):717-728. PubMed ID: 30295338 [TBL] [Abstract][Full Text] [Related]
17. Evolving Thrombolytics: from Alteplase to Tenecteplase. Miller SE; Warach SJ Neurotherapeutics; 2023 Apr; 20(3):664-678. PubMed ID: 37273127 [TBL] [Abstract][Full Text] [Related]
18. Functional Outcome and Hemorrhage Rates After Bridging Therapy With Tenecteplase or Alteplase in Patients With Large Ischemic Core. Gerschenfeld G; Turc G; Obadia M; Chausson N; Consoli A; Olindo S; Caroff J; Marnat G; Blanc R; Ben Hassen W; Seners P; Guillon B; Wiener E; Bourcier R; Yger M; Cho TH; Checkouri T; Gory B; Smadja D; Sibon I; Richard S; Piotin M; Eker OF; Pico F; Lapergue B; Alamowitch S; Neurology; 2024 Jul; 103(1):e209398. PubMed ID: 38862134 [TBL] [Abstract][Full Text] [Related]
19. Comparison of Tenecteplase with Alteplase on clinical rating scores following small clot embolic strokes in rabbits. Lapchak PA; Araujo DM; Zivin JA Exp Neurol; 2004 Jan; 185(1):154-9. PubMed ID: 14697326 [TBL] [Abstract][Full Text] [Related]